5-136029105-G-C
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000358.3(TGFBI):c.50G>C(p.Gly17Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,525,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000358.3 missense
Scores
Clinical Significance
Conservation
Publications
- epithelial-stromal TGFBI dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- granular corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- granular corneal dystrophy type IIInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- lattice corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Reis-Bucklers corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- Thiel-Behnke corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- epithelial basement membrane dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBI | NM_000358.3 | c.50G>C | p.Gly17Ala | missense_variant | Exon 1 of 17 | ENST00000442011.7 | NP_000349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBI | ENST00000442011.7 | c.50G>C | p.Gly17Ala | missense_variant | Exon 1 of 17 | 1 | NM_000358.3 | ENSP00000416330.2 | ||
TGFBI | ENST00000504185.5 | n.118G>C | non_coding_transcript_exon_variant | Exon 1 of 5 | 4 | |||||
TGFBI | ENST00000506699.5 | n.115G>C | non_coding_transcript_exon_variant | Exon 1 of 17 | 2 | |||||
TGFBI | ENST00000507018.5 | n.-35G>C | upstream_gene_variant | 5 | ENSP00000421540.1 |
Frequencies
GnomAD3 genomes AF: 0.000710 AC: 108AN: 152134Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000912 AC: 11AN: 120578 AF XY: 0.0000150 show subpopulations
GnomAD4 exome AF: 0.0000662 AC: 91AN: 1373658Hom.: 0 Cov.: 31 AF XY: 0.0000443 AC XY: 30AN XY: 677928 show subpopulations
GnomAD4 genome AF: 0.000709 AC: 108AN: 152250Hom.: 1 Cov.: 32 AF XY: 0.000645 AC XY: 48AN XY: 74426 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.50G>C (p.G17A) alteration is located in exon 1 (coding exon 1) of the TGFBI gene. This alteration results from a G to C substitution at nucleotide position 50, causing the glycine (G) at amino acid position 17 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
TGFBI-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at